Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable-Reference-Cited by-同舟云学术

Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable

Published:2018-01-15 Issue:4 Volume:57 Page:666-670
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Devauchelle-Pensec Valérie¹²,Saraux Lea¹³,Berthelot Jean Marie⁴,De Bandt Michel⁵,Cornec Divi¹²,Guellec Dewi¹,Marhadour Thierry¹,Jousse-Joulin Sandrine¹²,Gouillou Maelenn⁶,Saraux Alain¹²

Affiliation:

1. Rheumatology Department, CHU Brest, , Brest, France

2. INSERM UMR 1227, Laboratoire d’Immunothérapie et Pathologies lymphocytaires B, Labex ‘Immunotherapy, Graft, Oncology’, Université Bretagne occidentale, 29609 Brest Cedex, Brest, France

3. Institut supérieur de l’électronique et du numérique (ISEN), Brest, France

4. Rheumatology Department, Hôtel Dieu University Hospital, Nantes, Brest, France

5. Rheumatology Department, Fort de France, Martinique, Brest, France

6. Clinical Investigation Centre [CIC] 1412, Institut National de la Santé et de la Recherche Médicale [INSERM], Brest, France

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/57/4/666/24459412/kex477.pdf

Reference15 articles.

1. A disease activity score for polymyalgia rheumatica;Leeb;Ann Rheum Dis,2004